Transcode Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Transcode Therapeutics, Inc.
CIK #0001829635
EDGAR Form CIK 2011 - 2025
10-K [0001829635]
10-Q [0001829635]
3 [0001829635]
4 [0001829635]
8-K [0001829635]
D [0001829635]
SC 13D [0001829635]
SC 13G [0001829635]
Form 13D/13G Filer Form 13D/13G Subject Filed
Goldman Sachs Group Inc Transcode Therapeutics Inc [2025-08-14]
Tracy Thomas Joseph Transcode Therapeutics Inc [2025-03-20]
Anson Funds Management LP Transcode Therapeutics Inc [2025-02-14]
Sabby Management LLC Transcode Therapeutics Inc [2025-01-03]
3I LP Transcode Therapeutics Inc [2024-07-26]
Fitzgerald Thomas A Transcode Therapeutics Inc [2024-06-21]
Lind Global Fund II LP Transcode Therapeutics Inc [2023-12-07]
Tang Capital Partners LP Transcode Therapeutics Inc [2023-09-26]
Dudley Robert Michael Transcode Therapeutics Inc [2022-12-20]
Dudley Robert Michael Transcode Therapeutics Inc [2022-12-20]
View All
Form 3/4/5 Subject 2011 - 2025
Fitzgerald Thomas A
Transcode Therapeutics, Inc.
Manting Erik
Marquet Magda
Calais Philippe
Dudley Robert Michael
Medarova Zdravka
Moore Anna
Terms | Privacy | Guide
tony@aum13f.com